Drug profile · INN
asunaprevir
SUNVEPRA
asunaprevir (SUNVEPRA) is a hepatitis c virus serine protease, ns3/ns4a inhibitor.
PMDA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — asunaprevir
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.78
Quick answer
asunaprevir (SUNVEPRA) is a hepatitis c virus serine protease, ns3/ns4a inhibitor.
Key facts
INN asunaprevir
Brand SUNVEPRA
Mechanism Hepatitis C virus serine protease, NS3/NS4A inhibitor
Target Hepatitis C virus serine protease, NS3/NS4A
Mechanism of action
Hepatitis C virus serine protease, NS3/NS4A inhibitor
Primary target: Hepatitis C virus serine protease, NS3/NS4A
Approval history
| Authority | Status | Date |
|---|---|---|
| PMDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is asunaprevir?
asunaprevir (SUNVEPRA) is a hepatitis c virus serine protease, ns3/ns4a inhibitor.
What is the brand name for asunaprevir?
SUNVEPRA is a marketed brand name for asunaprevir. Check FDA Drugs@FDA for the current US label holder and prescribing information.